Weight-loss drug approved to reduce risk of non-fatal heart attacks | Canada Tonight
Health Canada has approved the weight-loss drug Wegovy to reduce the risk of non-fatal heart attacks, drug maker Novo Nordisk says. But how does it work? Dr. Samir Gupta discusses Health Canada's decision.
2:18
0:40
1:25
2:09
2:59
4:55
12:24
1:59
2:11
2:12
